NC-Based Regado Biosciences Completes $23 Million Series C Financing
Durham, NC- Regado Biosciences, Inc., a privately-held biopharmaceutical company focused on the discovery and development of antidote-controlled antithrombotics, announced today the completion of a $23 million Series C financing.
http://www.regadobiosciences.com/graphics/Regado%20Series%20C%20press%20release.pdf

